{
  "drug_name": "Cocarboxylase",
  "generic_name": [
    "LEVOMEFOLATE MAGNESIUM, LEUCOVORIN, FOLIC ACID, FERROUS CYSTEINE GLYCINATE, MAGNESIUM ASCORBATE, ZINC ASCORBATE, COCARBOXYLASE, FLAVIN ADENINE DINUCLEOTIDE, NADH, PYRIDOXAL PHOSPHATE ANHYDROUS, COBAMAMIDE, BETAINE, MAGNESIUM L-THREONATE, 1,2-DOCOSAHEXANOYL-SN-GLYCERO-3-PHOSPHOSERINE CALCIUM, 1,2-ICOSAPENTOYL-SN-GLYCERO-3-PHOSPHOSERINE CALCIUM, AND PHOSPHATIDYL SERINE"
  ],
  "brand_names": [
    "EnBrace HR"
  ],
  "drug_interactions": [],
  "warnings": [],
  "adverse_reactions": [
    "ADVERSE REACTIONS: Mild transient diarrhea, polycythemia vera, itching, transitory exanthema, feeling of swelling of entire body may occur with administration of vitamin B 12 . Allergic sensitization has been reported following both oral and parenteral administration of folic acid."
  ],
  "contraindications": [],
  "dosage_administration": [
    "DOSAGE AND ADMINISTRATION \u200b: The adult dose is one capsule daily preferably on an empty stomach . As a general rule reticulocyte plasma count, folate and vitamin B 12 status must be obtained prior to treatment. Do not exceed recommended dose. Call your medical practitioner about side effects. You may report side effects by calling 337.662-5962."
  ],
  "indications": [
    "iNDICATIONS: EnBrace\u00ae HR is indicated in the TREATMENT of vitamin deficiency - specifically vitamin B 12 deficiency, and the PREVENTION of vitamin B 12 -cofactor deficiency, l-methylfolate. Requirements of vitamin B 9 and/or vitamin B 12 in excess of normal due to pregnancy can usually be met with oral supplementation."
  ],
  "fetched_at": "2025-10-01T02:38:24.595818",
  "source": "OpenFDA"
}